Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Access to Genetic Counselor Services Act of 2021
Client: INVITAE INC. · Firm: IPOLICY SOLUTIONS
H.R.5989 - Precision Medicine Answers for Kids Today Act H.R. 2144, Access to Genetic Counselor Services Act H.R. 2903 CONNECT for Health Act H.R. 708, TREAT Act H.R.6202 - Telehealth Extension Act of 2021 Molecular Pathology Coding and Reimbursement Oncology Care Model
Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021
Client: INVITAE INC. · Firm: IPOLICY SOLUTIONS
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
GENEDX, INC. via IPOLICY SOLUTIONS
2022 · second_quarter · 2A
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TWIST BIOSCIENCE CORPORATION via IPOLICY SOLUTIONS
2022 · second_quarter · 2A
Source: Senate LDA
| CLEAR LABS |
| 2 |
| 2021 |
H.R.5989 - Precision Medicine Answers for Kids Today Act H.R. 2144, Access to Genetic Counselor Services Act H.R. 2903 CONNECT for Health Act H.R. 708, TREAT Act H.R.6202 - Telehealth Extension Act of 2021 Molecular Pathology Coding and Reimbursement Oncology Care Model
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022 FDA Draft Guidance on ctDNA
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act S.4348 - FDASLA Act of 2022
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act S.4348 - FDASLA Act of 2022
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022 FDA Draft Guidance on ctDNA
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022 FDA Draft Guidance on ctDNA
United States Innovation and Competition Act of 2021
Client: TWIST BIOSCIENCE CORPORATION · Firm: IPOLICY SOLUTIONS
Biosecurity standards American competitiveness H.R.4521/S.1418 Bioeconomy Research and Development Act of 2021 H.R.4521 - America COMPETES Act S.1260 - United States Innovation and Competition Act
United States Innovation and Competition Act of 2021
Client: TWIST BIOSCIENCE CORPORATION · Firm: IPOLICY SOLUTIONS
Biosecurity standards American competitiveness H.R.4521/S.1418 Bioeconomy Research and Development Act of 2021 H.R.4521 - America COMPETES Act S.1260 - United States Innovation and Competition Act
United States Innovation and Competition Act of 2021
Client: TWIST BIOSCIENCE CORPORATION · Firm: IPOLICY SOLUTIONS
Biosecurity standards American competitiveness H.R.4521/S.1418 Bioeconomy Research and Development Act of 2021 H.R.4521 - America COMPETES Act S.1260 - United States Innovation and Competition Act
Precision Medicine Answers for Kids Today Act
Client: INVITAE INC. · Firm: IPOLICY SOLUTIONS
H.R.5989 - Precision Medicine Answers for Kids Today Act H.R. 2144, Access to Genetic Counselor Services Act H.R. 2903 CONNECT for Health Act H.R. 708, TREAT Act H.R.6202 - Telehealth Extension Act of 2021 Molecular Pathology Coding and Reimbursement Oncology Care Model
Precision Medicine Answers for Kids Today Act
Client: INVITAE INC. · Firm: IPOLICY SOLUTIONS
H.R.5989 - Precision Medicine Answers for Kids Today Act Molecular Pathology Coding and Reimbursement Oncology Care Model Medicare Promoting Interoperability Program Information blocking
Precision Medicine Answers for Kids Today Act
Client: INVITAE INC. · Firm: IPOLICY SOLUTIONS
H.R.5989 - Precision Medicine Answers for Kids Today Act Molecular Pathology Coding and Reimbursement Oncology Care Model
Precision Medicine Answers for Kids Today Act
Client: INVITAE INC. · Firm: IPOLICY SOLUTIONS
H.R.5989 - Precision Medicine Answers for Kids Today Act Molecular Pathology Coding and Reimbursement Oncology Care Model Medicare Promoting Interoperability Program Information blocking
H.R. 6000 Cures 2.0 Act H.R.6875 - Right Drug Dose Now Act S.3799 - PREVENT Pandemics Act Cancer Moonshot
H.R. 6000 Cures 2.0 Act H.R.6875 - Right Drug Dose Now Act S.3799 - PREVENT Pandemics Act Cancer Moonshot
H.R. 6000 Cures 2.0 Act H.R.6875 - Right Drug Dose Now Act S.3799 - PREVENT Pandemics Act Cancer Moonshot
H.R. 6000 Cures 2.0 Act H.R.6875 - Right Drug Dose Now Act S.3799 - PREVENT Pandemics Act Cancer Moonshot
H.R.5989 - Precision Medicine Answers for Kids Today Act H.R. 2144, Access to Genetic Counselor Services Act H.R. 2903 CONNECT for Health Act H.R. 708, TREAT Act H.R.6202 - Telehealth Extension Act of 2021 Molecular Pathology Coding and Reimbursement Oncology Care Model
Telehealth Extension Act of 2021
Client: EVERLY HEALTH (FORMERLY KNOWN AS EVERLYWELL) · Firm: IPOLICY SOLUTIONS
S.3799 - PREVENT Pandemics Act H.R.6202 - Telehealth Extension Act of 2021 S. 3593 - Telehealth Evaluation and Extension Act of 2022
H.R. 6000 Cures 2.0 Act H.R.6875 - Right Drug Dose Now Act S.3799 - PREVENT Pandemics Act Cancer Moonshot
H.R. 6000 Cures 2.0 Act H.R.6875 - Right Drug Dose Now Act S.3799 - PREVENT Pandemics Act Cancer Moonshot
H.R. 6000 Cures 2.0 Act H.R.6875 - Right Drug Dose Now Act S.3799 - PREVENT Pandemics Act Cancer Moonshot
H.R. 6000 Cures 2.0 Act H.R.6875 - Right Drug Dose Now Act S.3799 - PREVENT Pandemics Act Cancer Moonshot
H.R.5989 - Precision Medicine Answers for Kids Today Act H.R. 2144, Access to Genetic Counselor Services Act H.R. 2903 CONNECT for Health Act H.R. 708, TREAT Act H.R.6202 - Telehealth Extension Act of 2021 Molecular Pathology Coding and Reimbursement Oncology Care Model
United States Innovation and Competition Act of 2021
Client: TWIST BIOSCIENCE CORPORATION · Firm: IPOLICY SOLUTIONS
Biosecurity standards American competitiveness H.R.4521/S.1418 Bioeconomy Research and Development Act of 2021 H.R.4521 - America COMPETES Act S.1260 - United States Innovation and Competition Act
United States Innovation and Competition Act of 2021
Client: TWIST BIOSCIENCE CORPORATION · Firm: IPOLICY SOLUTIONS
Biosecurity standards American competitiveness H.R.4521/S.1418 Bioeconomy Research and Development Act of 2021 H.R.4521 - America COMPETES Act S.1260 - United States Innovation and Competition Act
United States Innovation and Competition Act of 2021
Client: TWIST BIOSCIENCE CORPORATION · Firm: IPOLICY SOLUTIONS
Biosecurity standards American competitiveness H.R.4521/S.1418 Bioeconomy Research and Development Act of 2021 H.R.4521 - America COMPETES Act S.1260 - United States Innovation and Competition Act
Bioeconomy Research and Development Act of 2021
Client: TWIST BIOSCIENCE CORPORATION · Firm: IPOLICY SOLUTIONS
Biosecurity standards American competitiveness H.R.4521/S.1418 Bioeconomy Research and Development Act of 2021 H.R.4521 - America COMPETES Act S.1260 - United States Innovation and Competition Act
Bioeconomy Research and Development Act of 2021
Client: TWIST BIOSCIENCE CORPORATION · Firm: IPOLICY SOLUTIONS
Biosecurity standards American competitiveness H.R.4521/S.1418 Bioeconomy Research and Development Act of 2021 H.R.4521 - America COMPETES Act S.1260 - United States Innovation and Competition Act
Bioeconomy Research and Development Act of 2021
Client: TWIST BIOSCIENCE CORPORATION · Firm: IPOLICY SOLUTIONS
Biosecurity standards American competitiveness H.R.4521/S.1418 Bioeconomy Research and Development Act of 2021 H.R.4521 - America COMPETES Act S.1260 - United States Innovation and Competition Act
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act S.4348 - FDASLA Act of 2022
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act S.4348 - FDASLA Act of 2022
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022 FDA Draft Guidance on ctDNA
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022 FDA Draft Guidance on ctDNA
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022 FDA Draft Guidance on ctDNA
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act S.4348 - FDASLA Act of 2022
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act S.4348 - FDASLA Act of 2022
Telehealth Extension and Evaluation Act
Client: EVERLY HEALTH (FORMERLY KNOWN AS EVERLYWELL) · Firm: IPOLICY SOLUTIONS
S.3799 - PREVENT Pandemics Act H.R.6202 - Telehealth Extension Act of 2021 S. 3593 - Telehealth Evaluation and Extension Act of 2022
H.R. 6000 Cures 2.0 Act H.R.6875 - Right Drug Dose Now Act S.3799 - PREVENT Pandemics Act Cancer Moonshot
S.3799, PREVENT Pandemics Act Pandemic response and supply chain issues
H.R. 6000 Cures 2.0 Act H.R.6875 - Right Drug Dose Now Act S.3799 - PREVENT Pandemics Act Cancer Moonshot
PREVENT Pandemics Act
Client: EVERLY HEALTH (FORMERLY KNOWN AS EVERLYWELL) · Firm: IPOLICY SOLUTIONS
S.3799 - PREVENT Pandemics Act H.R.6202 - Telehealth Extension Act of 2021 S. 3593 - Telehealth Evaluation and Extension Act of 2022
S.3799, PREVENT Pandemics Act Pandemic response and supply chain issues
H.R. 6000 Cures 2.0 Act H.R.6875 - Right Drug Dose Now Act S.3799 - PREVENT Pandemics Act Cancer Moonshot
H.R. 6000 Cures 2.0 Act H.R.6875 - Right Drug Dose Now Act S.3799 - PREVENT Pandemics Act Cancer Moonshot
S.3799, PREVENT Pandemics Act Pandemic response and supply chain issues
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022 FDA Draft Guidance on ctDNA
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act S.4348 - FDASLA Act of 2022
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022 FDA Draft Guidance on ctDNA
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022 FDA Draft Guidance on ctDNA
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act S.4348 - FDASLA Act of 2022
Access to Genetic Counselor Services Act of 2021
Client: INVITAE INC. · Firm: IPOLICY SOLUTIONS
No bill number, Advancing Access to Precision Medicine Act H.R. 2144, Access to Genetic Counselor Services Act H.R. 2903 CONNECT for Health Act H.R. 708, TREAT Act Molecular Pathology Coding and Reimbursement
Access to Genetic Counselor Services Act of 2021
Client: INVITAE INC. · Firm: IPOLICY SOLUTIONS
H.R.5989 - Precision Medicine Answers for Kids Today Act H.R. 2144, Access to Genetic Counselor Services Act H.R. 2903 CONNECT for Health Act H.R. 708, TREAT Act H.R.6202 - Telehealth Extension Act of 2021 Molecular Pathology Coding and Reimbursement Oncology Care Model
Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021
Client: INVITAE INC. · Firm: IPOLICY SOLUTIONS
No bill number, Advancing Access to Precision Medicine Act H.R. 2144, Access to Genetic Counselor Services Act H.R. 2903 CONNECT for Health Act H.R. 708, TREAT Act Molecular Pathology Coding and Reimbursement
Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021
Client: INVITAE INC. · Firm: IPOLICY SOLUTIONS
H.R.5989 - Precision Medicine Answers for Kids Today Act H.R. 2144, Access to Genetic Counselor Services Act H.R. 2903 CONNECT for Health Act H.R. 708, TREAT Act H.R.6202 - Telehealth Extension Act of 2021 Molecular Pathology Coding and Reimbursement Oncology Care Model
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act NIH/FDA Request for Information on tools for next generation sequencing
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act
No bill number, The Right Act HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
No bill number, The Right Act HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022
Client: INVITAE INC. · Firm: IPOLICY SOLUTIONS
H.R.4355 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022 S.2604 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022
Client: INVITAE INC. · Firm: IPOLICY SOLUTIONS
H.R.4355 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022 S.2604 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022
United States Innovation and Competition Act of 2021
Client: TWIST BIOSCIENCE CORPORATION · Firm: IPOLICY SOLUTIONS
Biosecurity standards American competitiveness H.R.4521/S.1418 Bioeconomy Research and Development Act of 2021
United States Innovation and Competition Act of 2021
Client: TWIST BIOSCIENCE CORPORATION · Firm: IPOLICY SOLUTIONS
Biosecurity standards American competitiveness H.R.4521/S.1418 Bioeconomy Research and Development Act of 2021
Precision Medicine Answers for Kids Today Act
Client: INVITAE INC. · Firm: IPOLICY SOLUTIONS
H.R.5989 - Precision Medicine Answers for Kids Today Act H.R. 2144, Access to Genetic Counselor Services Act H.R. 2903 CONNECT for Health Act H.R. 708, TREAT Act H.R.6202 - Telehealth Extension Act of 2021 Molecular Pathology Coding and Reimbursement Oncology Care Model
H.R. 6000 Cures 2.0 Act
H.R.5989 - Precision Medicine Answers for Kids Today Act H.R. 2144, Access to Genetic Counselor Services Act H.R. 2903 CONNECT for Health Act H.R. 708, TREAT Act H.R.6202 - Telehealth Extension Act of 2021 Molecular Pathology Coding and Reimbursement Oncology Care Model
No bill number, Advancing Access to Precision Medicine Act H.R. 2144, Access to Genetic Counselor Services Act H.R. 2903 CONNECT for Health Act H.R. 708, TREAT Act Molecular Pathology Coding and Reimbursement
H.R.5989 - Precision Medicine Answers for Kids Today Act H.R. 2144, Access to Genetic Counselor Services Act H.R. 2903 CONNECT for Health Act H.R. 708, TREAT Act H.R.6202 - Telehealth Extension Act of 2021 Molecular Pathology Coding and Reimbursement Oncology Care Model
Bioeconomy Research and Development Act of 2021
Client: TWIST BIOSCIENCE CORPORATION · Firm: IPOLICY SOLUTIONS
Biosecurity standards American competitiveness H.R.4521/S.1418 Bioeconomy Research and Development Act of 2021
Bioeconomy Research and Development Act of 2021
Client: TWIST BIOSCIENCE CORPORATION · Firm: IPOLICY SOLUTIONS
Biosecurity standards American competitiveness H.R.4521/S.1418 Bioeconomy Research and Development Act of 2021
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act NIH/FDA Request for Information on tools for next generation sequencing
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act
No bill number, The Right Act HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
No bill number, The Right Act HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act NIH/FDA Request for Information on tools for next generation sequencing
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022
Client: INVITAE INC. · Firm: IPOLICY SOLUTIONS
H.R.4355 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022 S.2604 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022
Client: INVITAE INC. · Firm: IPOLICY SOLUTIONS
H.R.4355 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022 S.2604 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022
Biosecurity standards American competitiveness H.R.4521/S.1418 Bioeconomy Research and Development Act of 2021 H.R.4521 - America COMPETES Act S.1260 - United States Innovation and Competition Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INVITAE INC. via IPOLICY SOLUTIONS
2022 · second_quarter · 2A
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022 FDA Draft Guidance on ctDNA
H.R. 6000 Cures 2.0 Act H.R.6875 - Right Drug Dose Now Act S.3799 - PREVENT Pandemics Act Cancer Moonshot
H.R.5989 - Precision Medicine Answers for Kids Today Act Molecular Pathology Coding and Reimbursement Oncology Care Model Medicare Promoting Interoperability Program Information blocking
U.S. Patent Act Sec. 101 reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via IPOLICY SOLUTIONS
2022 · second_quarter · 2A
S.3799, PREVENT Pandemics Act Pandemic response and supply chain issues
U.S. Patent Act Sec. 101 Reforms
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act S.4348 - FDASLA Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
GENEDX, INC. via IPOLICY SOLUTIONS
2022 · second_quarter · Q2
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TWIST BIOSCIENCE CORPORATION via IPOLICY SOLUTIONS
2022 · second_quarter · Q2
Biosecurity standards American competitiveness H.R.4521/S.1418 Bioeconomy Research and Development Act of 2021 H.R.4521 - America COMPETES Act S.1260 - United States Innovation and Competition Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INVITAE INC. via IPOLICY SOLUTIONS
2022 · second_quarter · 2A
U.S. Patent Act Sec. 101 reform
H.R.5989 - Precision Medicine Answers for Kids Today Act Molecular Pathology Coding and Reimbursement Oncology Care Model Medicare Promoting Interoperability Program Information blocking
H.R. 6000 Cures 2.0 Act H.R.6875 - Right Drug Dose Now Act S.3799 - PREVENT Pandemics Act Cancer Moonshot
INVITAE INC. via IPOLICY SOLUTIONS
2022 · second_quarter · Q2
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022 FDA Draft Guidance on ctDNA
U.S. Patent Act Sec. 101 reform
H.R.5989 - Precision Medicine Answers for Kids Today Act Molecular Pathology Coding and Reimbursement Oncology Care Model
ASSOCIATION FOR MOLECULAR PATHOLOGY via IPOLICY SOLUTIONS
2022 · second_quarter · Q2
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act S.4348 - FDASLA Act of 2022
U.S. Patent Act Sec. 101 Reforms
S.3799, PREVENT Pandemics Act Pandemic response and supply chain issues
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
GENEDX, INC. via IPOLICY SOLUTIONS
2022 · first_quarter · Q1
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EVERLY HEALTH (FORMERLY KNOWN AS EVERLYWELL) via IPOLICY SOLUTIONS
2022 · first_quarter · Q1
S.3799 - PREVENT Pandemics Act H.R.6202 - Telehealth Extension Act of 2021 S. 3593 - Telehealth Evaluation and Extension Act of 2022
Filing targets: SENATE
TWIST BIOSCIENCE CORPORATION via IPOLICY SOLUTIONS
2022 · first_quarter · Q1
Biosecurity standards American competitiveness H.R.4521/S.1418 Bioeconomy Research and Development Act of 2021 H.R.4521 - America COMPETES Act S.1260 - United States Innovation and Competition Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SEMA4 (FORMERLY KNOWN AS MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4)) via IPOLICY SOLUTIONS
2022 · first_quarter · Q1
Medicare reimbursement for comprehensive genomic profiling
Filing targets: SENATE
INVITAE INC. via IPOLICY SOLUTIONS
2022 · first_quarter · Q1
H.R. 6000 Cures 2.0 Act H.R.6875 - Right Drug Dose Now Act S.3799 - PREVENT Pandemics Act Cancer Moonshot
U.S. Patent Act Sec. 101 reform
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
ASSOCIATION FOR MOLECULAR PATHOLOGY via IPOLICY SOLUTIONS
2022 · first_quarter · Q1
U.S. Patent Act Sec. 101 Reforms
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act
S.3799, PREVENT Pandemics Act Pandemic response and supply chain issues
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
SEMA4 (FORMERLY KNOWN AS MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4)) via IPOLICY SOLUTIONS
2021 · fourth_quarter · Q4
Medicare reimbursement for comprehensive genomic profiling
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENEDX, INC. via IPOLICY SOLUTIONS
2021 · fourth_quarter · RR
Oversight of diagnostics Medicaid coverage of genetic tests
Oversight of diagnostics Medicaid coverage of genetic tests
CLEAR LABS via IPOLICY SOLUTIONS
2021 · fourth_quarter · 4T
Medicare Program; Medicare Coverage of Innovative Technology (MCIT) and Definition of Reasonable and Necessary (CMS-3372-P2)
Genomic sequencing COVID-19 NIH/FDA Request for Information on Tools for NGS Test Validation and Development
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
EVERLY HEALTH (FORMERLY KNOWN AS EVERLYWELL) via IPOLICY SOLUTIONS
2021 · fourth_quarter · Q4
Access to COVID-19 therapies
Filing targets: SENATE
TWIST BIOSCIENCE CORPORATION via IPOLICY SOLUTIONS
2021 · fourth_quarter · Q4
Biosecurity standards American competitiveness H.R.4521/S.1418 Bioeconomy Research and Development Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVITAE INC. via IPOLICY SOLUTIONS
2021 · fourth_quarter · Q4
No bill number, The Right Act HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
H.R.4355 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022 S.2604 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022
H.R. 6000 Cures 2.0 Act
ASSOCIATION FOR MOLECULAR PATHOLOGY via IPOLICY SOLUTIONS
2021 · fourth_quarter · Q4
U.S. Patent Act Sec. 101 Reforms
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SEMA4 (FORMERLY KNOWN AS MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4)) via IPOLICY SOLUTIONS
2021 · third_quarter · Q3
Medicare reimbursement for comprehensive genomic profiling
Filing targets: SENATE
EVERLY HEALTH (FORMERLY KNOWN AS EVERLYWELL) via IPOLICY SOLUTIONS
2021 · third_quarter · Q3
Access to COVID-19 therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SEMA4 (FORMERLY KNOWN AS MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4)) via IPOLICY SOLUTIONS
2021 · third_quarter · RA
Medicare reimbursement for comprehensive genomic profiling
EVERLY HEALTH (FORMERLY KNOWN AS EVERLYWELL) via IPOLICY SOLUTIONS
2021 · third_quarter · RA
Access to COVID-19 therapies
CLEAR LABS via IPOLICY SOLUTIONS
2021 · third_quarter · Q3
Medicare Program; Medicare Coverage of Innovative Technology (MCIT) and Definition of Reasonable and Necessary (CMS-3372-P2)
Genomic sequencing COVID-19 NIH/FDA Request for Information on tools for next generation sequencing
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, White House Office
TWIST BIOSCIENCE CORPORATION via IPOLICY SOLUTIONS
2021 · third_quarter · Q3
Biosecurity standards American competitiveness H.R.4521/S.1418 Bioeconomy Research and Development Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVITAE INC. via IPOLICY SOLUTIONS
2021 · third_quarter · Q3
No bill number, The Right Act HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
No bill number, Advancing Access to Precision Medicine Act H.R. 2144, Access to Genetic Counselor Services Act H.R. 2903 CONNECT for Health Act H.R. 708, TREAT Act Molecular Pathology Coding and Reimbursement
H.R.4355 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022 S.2604 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022
ASSOCIATION FOR MOLECULAR PATHOLOGY via IPOLICY SOLUTIONS
2021 · third_quarter · Q3
U.S. Patent Act Sec. 101 Reforms
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act NIH/FDA Request for Information on tools for next generation sequencing
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
TWIST BIOSCIENCE CORPORATION via IPOLICY SOLUTIONS
2021 · second_quarter · Q2
Biosecurity standards American competitiveness
No bill no., FY2022 Labor, Health and Human Services, Education, and Related Agencies Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVITAE INC. via IPOLICY SOLUTIONS
2021 · second_quarter · Q2
U.S. Patent Act Sec. 101 reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
ASSOCIATION FOR MOLECULAR PATHOLOGY via IPOLICY SOLUTIONS
2021 · second_quarter · Q2
U.S. Patent Act Sec. 101 Reforms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022 FDA Draft Guidance on ctDNA
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE
H.R. 6000 Cures 2.0 Act H.R.6875 - Right Drug Dose Now Act S.3799 - PREVENT Pandemics Act Cancer Moonshot
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE
H.R.5989 - Precision Medicine Answers for Kids Today Act H.R. 2144, Access to Genetic Counselor Services Act H.R. 2903 CONNECT for Health Act H.R. 708, TREAT Act H.R.6202 - Telehealth Extension Act of 2021 Molecular Pathology Coding and Reimbursement Oncology Care Model
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
U.S. Patent Act Sec. 101 reform
H.R.5989 - Precision Medicine Answers for Kids Today Act H.R. 2144, Access to Genetic Counselor Services Act H.R. 2903 CONNECT for Health Act H.R. 708, TREAT Act H.R.6202 - Telehealth Extension Act of 2021 Molecular Pathology Coding and Reimbursement Oncology Care Model
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
U.S. Patent Act Sec. 101 reform
Social determinants of health No bill number, Cures 2.0
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE